Sign in
4

Changes in Ownership

HCW Biologics Inc. Filed Acc 0001209191-21-055530

Options or other derivatives

  • See Remarks acquired 20,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table II: Derivative

Insider Date Transaction Shares Price Value Owned after D/I
Rhode Peter See Remarks 2021-09-08 Grant or award · Stock Option (Right to Buy) +20,000 20,000 D: show line 1 in the form
Loading xslF345X03/doc4.xml…